MindMaze Taps Vibra Partnership to Scale U.S. Neurorehab Platform

The latest update is out from RELIEF THERAPEUTICS Holding ( (CH:MMTX) ).

MindMaze Therapeutics has entered a definitive channel partnership agreement with Vibra Healthcare to expand deployment of its FDA-cleared digital neurorehabilitation platform across leading U.S. health systems. Vibra, a major post-acute care provider with a network of specialty hospitals and rehabilitation centers, will act as MindMaze Therapeutics’ strategic commercial partner in the U.S.

The agreement builds on Vibra’s two-year, multi-site rollout of the MindMaze Therapeutics platform in five inpatient rehabilitation facilities, which showed that high-dose, high-intensity therapy can be delivered at scale without adding staff. By leveraging Vibra’s national relationships, the partnership aims to help providers treat more patients at higher levels of care with existing resources and improve outcomes such as shorter inpatient stays and better community discharge rates, with MindMaze Therapeutics expecting a boost in U.S. customer acquisition from the second half of 2026 onward.

More about RELIEF THERAPEUTICS Holding

MindMaze Therapeutics, listed on the SIX Swiss Exchange, develops scalable precision neurotherapeutics that combine advanced software, proprietary sensors, and AI-driven analytics to support recovery for neurological patients from hospital to home-based care. Its FDA-cleared and CE-marked digital platforms target stroke, Parkinson’s disease, and other neurological disorders, aiming to address clinician shortages with reimbursable, clinically validated solutions.

Average Trading Volume: 724,809

Technical Sentiment Signal: Sell

Current Market Cap: CHF58.31M

See more data about MMTX stock on TipRanks’ Stock Analysis page.